What is the current cure rate for Peg-Intron Geno 4?

What are the percentages of people being cured with peg intron/Riba therapy? I know it has to have gone up from several years ago.

[Imagine]

I can

[l-horn]

Response rates for genotypes 2-6 is 75% with peg-intron dosage levels under 1.5 and under 800mg rebetol. For doses over that, it is 73%.

I don't know what the relapse rate is.

[goaltoterminate]

Thanks for the link.

[goaltoterminate]

Thank you both for your info.
Imagination makes all things possible...Virus free since month 3.

[l-horn]

http://www.spfiles.com/pipeg-intron.pdf

[Imagine]

Yes it does at that! That's great about being virus free since month 3. How many months/wks are you doing?

[goaltoterminate]

48 weeks. Have 7 shots left...piece a cake :)

[desrt]

I think this is a huge step backward for S-P to lump genotypes 2-6 together in their response rates. Everyone is agreed that geno 1 is the toughest, but there seems to be enough evidence to start listing 2 as the easiest, 3 as the next, and 4 somewhere between 1 and 3. Perhaps it's because this is a product insert from 2003, 2005 that new studies haven't been included. In 2002 my doctor was involved in an S-P study that took as it's starting premise that types 1 and 4 were the hardest to treat. Happily, it looks like 4 is a lot closer to a 3 and a 2, but there still needs to be more work done on this if we're to get individulized tx.

[Kalio1]

I agree with you on that one dsrt. Pretty dumb to lump them together from out POV, but from theirs it makes their product look better. Ah, marketing at it's best.


goaltoterminate

I read that genotype 4 should be treated the same as genotype 1, meaning treat for 48 weeks but I also read the success rate for genotype 4 was very similar to geno 2 and 3.

So it looks like the treaatment length is the same but the success rate is higher than geno 1. I've looked and looked for the dang article, can't find it. I thought I'd saved it but whatever I named it I can't recall. If I do find it I will post it.